Citius Pharmaceuticals, INC. (CTXR) SEC Filings — 2025
21 SEC filings for Citius Pharmaceuticals, INC. (CTXR) in 2025.
Filings
- Citius Pharma Goes Commercial with LYMPHIR Launch, Faces Going Concern Doubt — 10-K · Dec 23, 2025
- Citius Pharmaceuticals, INC. 8-K Filing — 8-K · Dec 1, 2025
- Citius Pharmaceuticals Files 8-K — 8-K · Oct 23, 2025
- Citius Pharmaceuticals Files 8-K — 8-K · Oct 21, 2025
- Citius Pharma's Q2 Loss Widens Amid R&D Spend — 10-Q · Aug 12, 2025
- Citius Pharmaceuticals Files 8-K — 8-K · Jul 8, 2025
- Citius Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jun 12, 2025
- Citius Pharma Files 8-K on Security Holder Rights & Bylaws — 8-K · Jun 9, 2025
- Citius Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jun 3, 2025
- Citius Pharmaceuticals Faces Delisting Notice — 8-K · May 30, 2025
- Citius Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Citius Pharma Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
- Citius Pharmaceuticals Files 8-K: Agreements, Equity Sales, Bylaw Changes — 8-K · Apr 18, 2025
- Citius Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 3, 2025
- Citius Pharmaceuticals Enters Material Definitive Agreement — 8-K · Apr 2, 2025
- Citius Pharma Files 8-K on Shareholder Votes — 8-K · Mar 10, 2025
- Citius Pharmaceuticals Files 10-Q for Q4 2024 — 10-Q · Feb 14, 2025
- Citius Pharmaceuticals Files 8-K — 8-K · Feb 6, 2025
- Citius Pharma Files 10-K/A Amendment — 10-K/A · Jan 27, 2025
- Citius Pharmaceuticals Files 8-K — 8-K · Jan 8, 2025
- Citius Pharmaceuticals Files 8-K with Exhibits — 8-K · Jan 7, 2025